Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

ALDX Aldeyra Therapeutics Inc

4,15

0,03 (0,73%)

08 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form SC 13G - Statement of acquisition of beneficial ownership by individuals

Aldeyra Therapeutics (NASDAQ:ALDX)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Aldeyra Therapeutics Charts.

Aldeyra Therapeutics (NASDAQ:ALDX)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Aldeyra Therapeutics Charts.

News Aldeyra Therapeutics Inc

Aldeyra Therapeutics Highlights Recent Preclinical Data in Obesity, Atopic Dermatitis, Pain, and Alcoholic Hepatitis, and Announces Planned Pivotal Clinical Trial in Retinitis Pigmentosa, at 2024 Research & Development Day
Donnerstag 25 April 2024 (2 Wochen vor) • Business Wire

Aldeyra Therapeutics to Host Research & Development Day on April 25, 2024
Donnerstag 18 April 2024 (3 Wochen vor) • Business Wire

Aldeyra Therapeutics Announces Clinical Development Plan for Resubmission of New Drug Application for Reproxalap in Dry Eye Disease
Donnerstag 28 März 2024 (1 Monat vor) • Business Wire

Form S-3 - Registration statement under Securities Act of 1933
Donnerstag 7 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Donnerstag 7 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Donnerstag 7 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Donnerstag 7 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Aldeyra Therapeutics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
Dienstag 6 Februar 2024 (3 Monate vor) • Business Wire

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Montag 29 Januar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 4 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Aldeyra Therapeutics Provides Clinical and Regulatory Update and Announces Advancement of RASP Platform in Systemic and Retinal Inflammatory Diseases
Donnerstag 4 Januar 2024 (4 Monate vor) • Business Wire

Form 8-K - Current report
Donnerstag 21 Dezember 2023 (5 Monate vor) • Edgar (US Regulatory)

Weitere Aldeyra Therapeutics Inc News-Artikel

Gold vs US Dollar

Deutsche Telekom

Energy Select Sector SPDR

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen